Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Atlantic Equities Maintains Underweight on Amgen, Lowers Price Target to $182

Atlantic Equities analyst Steve Chesney maintains Amgen (NASDAQ:AMGN) with a Underweight and lowers the price target from $190 to $182.
byBenzinga Newsdesk
August 9, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Atlantic Equities analyst Steve Chesney maintains Amgen (NASDAQ:AMGN) with a Underweight and lowers the price target from $190 to $182.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts